Diabetes Expansion The May 2025 Mila and Brian Mulroney Philanthropic Chair in Diabetes signals a strategic priority and dedicated fundraising potential. This creates opportunities to partner on diabetes-focused research programs, sponsor clinical trials, and engage donors with targeted grant writing and industry sponsorships.

Fundraising Opportunity Active philanthropic initiatives suggest readiness for donor CRM, campaign strategy, and grant management services. Offer end to end donor lifecycle solutions, bilingual outreach, and events management to maximize Quebec and international giving.

Academic Partnerships Affiliations with Université de Montréal and McGill provide a strong base for research administration outsourcing, joint grant submissions, and collaborative programs to accelerate translational science with industry partners.

Tech and Data A modern tech stack including Cloudflare, AWS, Google Search Console, and Microsoft 365 indicates demand for cloud modernization, cybersecurity, data governance, and analytics for biomedical research, as well as compliant CTMS/EDC solutions for trials.

Clinical Trials Access With five divisions, multiple clinics and a center for rare diseases, IRCM offers robust site access for patient recruitment and multicenter trials. Potential services include trial management, patient recruitment, and translational research partnerships.